Cargando…
Mortality during treatment for tuberculosis; a review of surveillance data in a rural county in Kenya
BACKGROUND: Globally in 2016, 1.7 million people died of Tuberculosis (TB). This study aimed to estimate all-cause mortality rate, identify features associated with mortality and describe trend in mortality rate from treatment initiation. METHOD: A 5-year (2012–2016) retrospective analysis of electr...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6622488/ https://www.ncbi.nlm.nih.gov/pubmed/31295277 http://dx.doi.org/10.1371/journal.pone.0219191 |
_version_ | 1783434164939259904 |
---|---|
author | Abdullahi, Osman A. Ngari, Moses M. Sanga, Deche Katana, Geoffrey Willetts, Annie |
author_facet | Abdullahi, Osman A. Ngari, Moses M. Sanga, Deche Katana, Geoffrey Willetts, Annie |
author_sort | Abdullahi, Osman A. |
collection | PubMed |
description | BACKGROUND: Globally in 2016, 1.7 million people died of Tuberculosis (TB). This study aimed to estimate all-cause mortality rate, identify features associated with mortality and describe trend in mortality rate from treatment initiation. METHOD: A 5-year (2012–2016) retrospective analysis of electronic TB surveillance data from Kilifi County, Kenya. The outcome was all-cause mortality within 180 days after starting TB treatment. The risk factors examined were demographic and clinical features at the time of starting anti-TB treatment. We performed survival analysis with time at risk defined from day of starting TB treatment to time of death, lost-to-follow-up or completing treatment. To account for ‘lost-to-follow-up’ we used competing risk analysis method to examine risk factors for all-cause mortality. RESULTS: 10,717 patients receiving TB treatment, median (IQR) age 33 (24–45) years were analyzed; 3,163 (30%) were HIV infected. Overall, 585 (5.5%) patients died; mortality rate of 12.2 (95% CI 11.3–13.3) deaths per 100 person-years (PY). Mortality rate increased from 7.8 (95% CI 6.4–9.5) in 2012 to 17.7 (95% CI 14.9–21.1) in 2016 per 100PY (P(trend)<0.0001). 449/585 (77%) of the deaths occurred within the first three months after starting TB treatment. The median time to death (IQR) declined from 87 (40–100) days in 2012 to 46 (18–83) days in 2016 (P(trend) = 0·04). Mortality rate per 100PY was 7.3 (95% CI 6.5–7.8) and 23.1 (95% CI 20.8–25.7) among HIV-uninfected and HIV-infected patients respectively. Age, being a female, extrapulmonary TB, being undernourished, HIV infected and year of diagnosis were significantly associated with mortality. CONCLUSIONS: We found most deaths occurred within three months and an increasing mortality rate during the time under review among patients on TB treatment. Our results therefore warrant further investigation to explore host, disease or health system factors that may explain this trend. |
format | Online Article Text |
id | pubmed-6622488 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-66224882019-07-25 Mortality during treatment for tuberculosis; a review of surveillance data in a rural county in Kenya Abdullahi, Osman A. Ngari, Moses M. Sanga, Deche Katana, Geoffrey Willetts, Annie PLoS One Research Article BACKGROUND: Globally in 2016, 1.7 million people died of Tuberculosis (TB). This study aimed to estimate all-cause mortality rate, identify features associated with mortality and describe trend in mortality rate from treatment initiation. METHOD: A 5-year (2012–2016) retrospective analysis of electronic TB surveillance data from Kilifi County, Kenya. The outcome was all-cause mortality within 180 days after starting TB treatment. The risk factors examined were demographic and clinical features at the time of starting anti-TB treatment. We performed survival analysis with time at risk defined from day of starting TB treatment to time of death, lost-to-follow-up or completing treatment. To account for ‘lost-to-follow-up’ we used competing risk analysis method to examine risk factors for all-cause mortality. RESULTS: 10,717 patients receiving TB treatment, median (IQR) age 33 (24–45) years were analyzed; 3,163 (30%) were HIV infected. Overall, 585 (5.5%) patients died; mortality rate of 12.2 (95% CI 11.3–13.3) deaths per 100 person-years (PY). Mortality rate increased from 7.8 (95% CI 6.4–9.5) in 2012 to 17.7 (95% CI 14.9–21.1) in 2016 per 100PY (P(trend)<0.0001). 449/585 (77%) of the deaths occurred within the first three months after starting TB treatment. The median time to death (IQR) declined from 87 (40–100) days in 2012 to 46 (18–83) days in 2016 (P(trend) = 0·04). Mortality rate per 100PY was 7.3 (95% CI 6.5–7.8) and 23.1 (95% CI 20.8–25.7) among HIV-uninfected and HIV-infected patients respectively. Age, being a female, extrapulmonary TB, being undernourished, HIV infected and year of diagnosis were significantly associated with mortality. CONCLUSIONS: We found most deaths occurred within three months and an increasing mortality rate during the time under review among patients on TB treatment. Our results therefore warrant further investigation to explore host, disease or health system factors that may explain this trend. Public Library of Science 2019-07-11 /pmc/articles/PMC6622488/ /pubmed/31295277 http://dx.doi.org/10.1371/journal.pone.0219191 Text en © 2019 Abdullahi et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Abdullahi, Osman A. Ngari, Moses M. Sanga, Deche Katana, Geoffrey Willetts, Annie Mortality during treatment for tuberculosis; a review of surveillance data in a rural county in Kenya |
title | Mortality during treatment for tuberculosis; a review of surveillance data in a rural county in Kenya |
title_full | Mortality during treatment for tuberculosis; a review of surveillance data in a rural county in Kenya |
title_fullStr | Mortality during treatment for tuberculosis; a review of surveillance data in a rural county in Kenya |
title_full_unstemmed | Mortality during treatment for tuberculosis; a review of surveillance data in a rural county in Kenya |
title_short | Mortality during treatment for tuberculosis; a review of surveillance data in a rural county in Kenya |
title_sort | mortality during treatment for tuberculosis; a review of surveillance data in a rural county in kenya |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6622488/ https://www.ncbi.nlm.nih.gov/pubmed/31295277 http://dx.doi.org/10.1371/journal.pone.0219191 |
work_keys_str_mv | AT abdullahiosmana mortalityduringtreatmentfortuberculosisareviewofsurveillancedatainaruralcountyinkenya AT ngarimosesm mortalityduringtreatmentfortuberculosisareviewofsurveillancedatainaruralcountyinkenya AT sangadeche mortalityduringtreatmentfortuberculosisareviewofsurveillancedatainaruralcountyinkenya AT katanageoffrey mortalityduringtreatmentfortuberculosisareviewofsurveillancedatainaruralcountyinkenya AT willettsannie mortalityduringtreatmentfortuberculosisareviewofsurveillancedatainaruralcountyinkenya |